ARCHIVES

Fragmin Cuts Risk Of VE By 50 Percent In Study

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

New Coalition To Lobby for Prevention

November 24, 1978

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000

In Brief: Zelen To Retire As Head Of ECOG Statistical Center; NIH Organizes Genome Research Center

October 20, 1989